DALLAS — Fotona, a global innovator in high-performance laser systems for aesthetic, dental, and gynecological applications, has named Jeff Duchemin as its new Group President and CEO. The leadership change, announced May 15, marks a strategic step in accelerating the company’s growth and global footprint.
Duchemin brings more than two decades of leadership experience in the medical technology and life sciences sectors. His resume includes executive roles at Becton Dickinson in its Interventional Surgery and Integrated Diagnostic Solutions businesses, as well as a previous tenure as President and CEO of Harvard Bioscience. Known for driving both organic growth and strategic acquisitions, Duchemin is expected to play a central role in advancing Fotona’s product innovation and expanding its international presence.
“Jeff is a visionary leader with a strong track record of global success in the life sciences and medical device industries,” said Jay Katzen, Executive Chairman of Fotona. “We’re excited to welcome him to the team as we enter a pivotal new chapter of innovation and market leadership.”
Duchemin holds an MBA from Southern New Hampshire University and a bachelor’s degree in accounting from the University of Massachusetts Dartmouth. In his new role, he aims to build on Fotona’s strong legacy of innovation, which spans six decades.
“Innovation is at the heart of Fotona,” said Duchemin. “I’m passionate about accelerating growth by enhancing current solutions and bringing new breakthrough technologies to market. With its talented team and world-class products, Fotona is well-positioned for its next phase of global expansion.”
Founded more than 60 years ago, Fotona is widely recognized for pioneering advances in laser technology, including the integration of dual Er:YAG and Nd:YAG laser wavelengths in a single system. The company continues to lead the field with the recent release of its Dynamis® Max platform, a next-generation aesthetic system designed to improve treatment versatility, usability, and efficiency across more than 100 advanced applications.
As Duchemin steps into his role, Fotona looks to strengthen its leadership position across core markets while pushing the boundaries of what’s possible in energy-based medical technologies.
